TR200103762T2 - Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı. - Google Patents
Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı.Info
- Publication number
- TR200103762T2 TR200103762T2 TR2001/03762T TR200103762T TR200103762T2 TR 200103762 T2 TR200103762 T2 TR 200103762T2 TR 2001/03762 T TR2001/03762 T TR 2001/03762T TR 200103762 T TR200103762 T TR 200103762T TR 200103762 T2 TR200103762 T2 TR 200103762T2
- Authority
- TR
- Turkey
- Prior art keywords
- disorders
- norcisapride
- bulimia
- optically pure
- apnea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Apne, apne bozukluklari, bulima nervosa, tahrisat yaratabilen bagirsak sendromu, idrarini tutamama, bradikardi, bradiaritmi, sinkop, baska bozukluklar ya da bunlarin semptomlarinin engellenmesi ya da kontrol altina alinmasi için, esas olarak (+) stereoizomerini barindirmayan (-) norsisaprid ya da farmasötik açidan kabul ediebilir bir tuzunun kullanimi.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8922598P | 1998-06-15 | 1998-06-15 | |
US12223699P | 1999-03-01 | 1999-03-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200103762T2 true TR200103762T2 (tr) | 2002-05-21 |
Family
ID=26780367
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/03758T TR200103758T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı. |
TR2001/03762T TR200103762T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı. |
TR2001/03757T TR200103757T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
TR2001/03759T TR200103759T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
TR2001/03760T TR200103760T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
TR2000/03707T TR200003707T2 (tr) | 1998-06-15 | 1999-06-10 | Apne , bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/03758T TR200103758T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı. |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/03757T TR200103757T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
TR2001/03759T TR200103759T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
TR2001/03760T TR200103760T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
TR2000/03707T TR200003707T2 (tr) | 1998-06-15 | 1999-06-10 | Apne , bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
Country Status (24)
Country | Link |
---|---|
US (2) | US6559165B1 (tr) |
EP (1) | EP1087765B1 (tr) |
JP (1) | JP2003522103A (tr) |
KR (3) | KR20060067985A (tr) |
CN (1) | CN1312716A (tr) |
AR (1) | AR020327A1 (tr) |
AT (1) | ATE291916T1 (tr) |
AU (1) | AU764474B2 (tr) |
BG (1) | BG105097A (tr) |
BR (1) | BR9911302A (tr) |
CA (1) | CA2334369A1 (tr) |
CZ (1) | CZ20004736A3 (tr) |
DE (1) | DE69924488T2 (tr) |
ES (1) | ES2237117T3 (tr) |
HK (1) | HK1040059A1 (tr) |
HU (1) | HUP0102026A3 (tr) |
IL (1) | IL140117A0 (tr) |
IS (1) | IS5755A (tr) |
NO (1) | NO20006358L (tr) |
NZ (3) | NZ526108A (tr) |
PL (1) | PL345325A1 (tr) |
SK (1) | SK19062000A3 (tr) |
TR (6) | TR200103758T2 (tr) |
WO (1) | WO1999065490A2 (tr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7160898B2 (en) * | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
US6362202B1 (en) * | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
US6835200B2 (en) | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
US6821285B2 (en) | 1999-06-22 | 2004-11-23 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6663639B1 (en) | 1999-06-22 | 2003-12-16 | Ndo Surgical, Inc. | Methods and devices for tissue reconfiguration |
US8287554B2 (en) | 1999-06-22 | 2012-10-16 | Ethicon Endo-Surgery, Inc. | Method and devices for tissue reconfiguration |
US7846180B2 (en) | 1999-06-22 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Tissue fixation devices and methods of fixing tissue |
US8512751B2 (en) | 2004-12-20 | 2013-08-20 | Collegium Pharmaceutical, Inc. | Pharmaceutical compositions for sleep disorders |
GB0524668D0 (en) * | 2005-12-02 | 2006-01-11 | Novartis Ag | Organic compounds |
US8852216B2 (en) | 2007-03-23 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Tissue approximation methods |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR748807A (fr) | 1932-03-10 | 1933-07-10 | Gulf Refining Co | Perfectionnements à la fabrication d'hydrocarbures |
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US4962115A (en) | 1981-10-01 | 1990-10-09 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
CA1183847A (en) | 1981-10-01 | 1985-03-12 | Georges Van Daele | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
US5137896A (en) | 1981-10-01 | 1992-08-11 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
US5057525A (en) | 1981-10-01 | 1991-10-15 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives |
US4598123A (en) | 1983-07-14 | 1986-07-01 | Unites States Steel Corporation | Impact modified methyl methacrylate polymer |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4800162A (en) | 1987-04-01 | 1989-01-24 | Sepracor, Inc. | Method for resolution of steroisomers in multiphase and extractive membrane reactors |
US5057427A (en) | 1988-04-07 | 1991-10-15 | Sepracor, Inc. | Method for resolution of stereoisomers |
US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
GB8823980D0 (en) * | 1988-10-13 | 1988-11-23 | Glaxo Group Ltd | Chemical compounds |
US5116407A (en) | 1988-10-13 | 1992-05-26 | Courtaulds Coatings Limited | Antifouling coatings |
JPH02188523A (ja) | 1989-01-13 | 1990-07-24 | M S C:Kk | 睡眠時無呼吸症治療薬 |
IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
US5075290A (en) | 1989-06-28 | 1991-12-24 | University Of Virginia Alumni Patents Foundation | Use of adenosine, adenosine analogs or nucleoside uptake blockers, e.g. dipyridamole, as drug treatments for obstructive sleep apnea and snoring |
US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5356934A (en) | 1990-03-29 | 1994-10-18 | Eli Lilly And Company | Selected serotonin subtype receptor agonist to treat sleep apnea |
US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
ATE170747T1 (de) * | 1991-12-21 | 1998-09-15 | Smithkline Beecham Plc | Verwendung von 5-ht4 - antagonisten zur herstellung eines arzneimittels zur behandlung von harninkontinenz |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
CA2139636A1 (en) | 1992-07-07 | 1994-01-20 | Nancy M. Gray | Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
EP1145715A3 (en) | 1992-07-07 | 2004-05-19 | Sepracor Inc. | Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
GB9310756D0 (en) * | 1993-05-25 | 1993-07-14 | Glaxo Lab Sa | Compositions |
WO1995001803A1 (en) | 1993-07-06 | 1995-01-19 | Merck & Co., Inc. | H2 antagonist-gastrointestinal motility agent combinations |
US5407953A (en) | 1994-02-04 | 1995-04-18 | Morgan; Julia A. | Treating apnea/hypopnea/snoring in humans |
US5502067A (en) | 1994-02-04 | 1996-03-26 | Morgan; Julia A. | Treating apneahypopnea/snoring in humans |
IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
US5712293A (en) | 1995-06-07 | 1998-01-27 | Sepracor, Inc. | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride |
FR2735475B1 (fr) * | 1995-06-13 | 1997-07-11 | Synthelabo | Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique |
US5739151A (en) | 1996-07-19 | 1998-04-14 | Sepracor Inc. | Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
JP3529102B2 (ja) * | 1997-07-11 | 2004-05-24 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノート シヤツプ | 5−ht3および5−ht4介在性障害に有用な(+)−ノルシサプリド |
EP1089733B1 (en) | 1998-06-15 | 2005-03-23 | Sepracor Inc. | Use of optically pure (+)-norcisapride for treating irritable bowel syndrome |
-
1999
- 1999-06-10 JP JP2000554370A patent/JP2003522103A/ja active Pending
- 1999-06-10 IL IL14011799A patent/IL140117A0/xx unknown
- 1999-06-10 KR KR1020067010978A patent/KR20060067985A/ko not_active Application Discontinuation
- 1999-06-10 BR BR9911302-3A patent/BR9911302A/pt not_active Application Discontinuation
- 1999-06-10 TR TR2001/03758T patent/TR200103758T2/tr unknown
- 1999-06-10 HU HU0102026A patent/HUP0102026A3/hu unknown
- 1999-06-10 DE DE69924488T patent/DE69924488T2/de not_active Expired - Fee Related
- 1999-06-10 PL PL99345325A patent/PL345325A1/xx not_active Application Discontinuation
- 1999-06-10 AU AU46784/99A patent/AU764474B2/en not_active Ceased
- 1999-06-10 TR TR2001/03762T patent/TR200103762T2/tr unknown
- 1999-06-10 WO PCT/US1999/013100 patent/WO1999065490A2/en not_active Application Discontinuation
- 1999-06-10 NZ NZ526108A patent/NZ526108A/en unknown
- 1999-06-10 AT AT99930196T patent/ATE291916T1/de not_active IP Right Cessation
- 1999-06-10 TR TR2001/03757T patent/TR200103757T2/tr unknown
- 1999-06-10 CA CA002334369A patent/CA2334369A1/en not_active Abandoned
- 1999-06-10 NZ NZ535055A patent/NZ535055A/en unknown
- 1999-06-10 SK SK1906-2000A patent/SK19062000A3/sk unknown
- 1999-06-10 CZ CZ20004736A patent/CZ20004736A3/cs unknown
- 1999-06-10 EP EP99930196A patent/EP1087765B1/en not_active Expired - Lifetime
- 1999-06-10 TR TR2001/03759T patent/TR200103759T2/tr unknown
- 1999-06-10 TR TR2001/03760T patent/TR200103760T2/tr unknown
- 1999-06-10 TR TR2000/03707T patent/TR200003707T2/tr unknown
- 1999-06-10 KR KR1020007014025A patent/KR20010052740A/ko not_active Application Discontinuation
- 1999-06-10 CN CN99809564A patent/CN1312716A/zh active Pending
- 1999-06-10 ES ES99930196T patent/ES2237117T3/es not_active Expired - Lifetime
- 1999-06-10 KR KR1020067003048A patent/KR20060020739A/ko not_active Application Discontinuation
- 1999-06-15 AR ARP990102864A patent/AR020327A1/es unknown
-
2000
- 2000-11-28 US US09/722,391 patent/US6559165B1/en not_active Expired - Fee Related
- 2000-12-08 IS IS5755A patent/IS5755A/is unknown
- 2000-12-12 NZ NZ508825A patent/NZ508825A/en unknown
- 2000-12-13 NO NO20006358A patent/NO20006358L/no unknown
- 2000-12-27 BG BG105097A patent/BG105097A/xx unknown
-
2002
- 2002-03-06 HK HK02101726.7A patent/HK1040059A1/zh unknown
-
2003
- 2003-02-26 US US10/372,875 patent/US7064138B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200003708T2 (tr) | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (+)-norsisapridin kullanımı. | |
NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
NO20070049L (no) | Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese | |
NO20002121L (no) | Benzotiazol-protein-tyrosin-kinaseinhibitorer | |
DE50306232D1 (de) | Ampholytisches copolymer und dessen verwendung | |
EA200600618A1 (ru) | Применение эффекторов глутаминил- и глутаматциклаз | |
IL151695A0 (en) | Substituted beta-carbolines with ikb-kinase inhibiting activity | |
ATE277929T1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
DE60315479D1 (de) | Pyrimidinamid derivate und deren verwendung | |
TR200103762T2 (tr) | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı. | |
WO2001081343A3 (en) | Compounds for treating fibromyalgia and chronic fatigue syndrome | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
DK1032556T3 (da) | Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder | |
CY1115255T1 (el) | Χρηση αναστολεων αποακετυλασης ιστονων για την φροντιδα philadelphia-αρνητικων μυελοπολλαπλασιαστικων συνδρομων | |
AP9801202A0 (en) | Atropisomers of 3-heteroaryl-4(3H)-quinazolinones. | |
NO20033318D0 (no) | 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav | |
PT1000046E (pt) | Derivados de piperazina activos no trato urinario inferior | |
YU39598A (sh) | Upotreba duloksetina i njegova farmaceutska smeša | |
PL357179A1 (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers | |
NO953892D0 (no) | Imidazolokinoksalinon-derivater som EAA-antagonister | |
NO20014081L (no) | Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier | |
BG105984A (bg) | Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението | |
ATE267194T1 (de) | Medikamente geeignet zur behandlung von proliferativen erkrankungen | |
TR200200987T2 (tr) | Kanser tedavisine yönelik,ornatılmış pirroller | |
GB2368524B (en) | Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders |